Sullivan, Bruyette, Speros & Blaney’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Sullivan, Bruyette, Speros & Blaney's AMGN Position: Q1 2021 in Review
Sullivan, Bruyette, Speros & Blaney reduced its Amgen (AMGN) stake by 1.3% in Q1 2021, selling an estimated $27K and leaving 8,628 shares worth $2.15M. The position accounts for 0.09% of the portfolio, ranked #64.
Sullivan, Bruyette, Speros & Blaney first reported a position in AMGN in Q2 2016 and has held it in 20 quarters since. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.
- Sullivan, Bruyette, Speros & Blaney held 8,628 shares of Amgen worth $2.15M as of Q1 2021.
- Sullivan, Bruyette, Speros & Blaney sold 113 Amgen shares in Q1 2021, an estimated $27K.
- Amgen made up 0.09% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #64 holding.
- Sullivan, Bruyette, Speros & Blaney first reported a position in Amgen in Q2 2016 and has held it in 20 quarters since.
- 2,219 funds tracked by Wall St. Rank held Amgen as of Q1 2021.
Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.